Abstract
In the hands of skilled microsurgeons a patency rate close to 90% can be expected in the surgical anastomosis of 1.0-mm vessels. Considering today’s instruments and techniques, however, if microsurgery is to progress to areas of new application (such as an occipital artery-posterior fossa bypass) several factors need to be overcome, one of the more important ones being consistent patency rates in vessels of 0.5-mm diameter.(1)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acland R. Signs of patency in small vessel anastomosis. Surgery 72:744, 1972
Acland R. Thrombus formation in microvascular surgery. Surgery 73:766, 1973
Acland R: Prevention of thrombus in microvascular surgery by the use of magnesium sulphate. Br J Plast Surg 25:292, 1972
Arfors KE: Counteraction of platelet activity at sites of laser-induced endothelial trauma. Br Med J 4:430, 1968
Arfors KE, Dahl DP, Engeset J, et al: In vivo quantitation of platelet activity using biolaser-induced endothelial injury. 5th European Conference on Microcirculation. Bibl Anat 10:502, 1969
Ball G, Brereton G, Ireland D, et al: Effect of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3,5-cyclic monophosphate. Biochem J 120:709, 1970
Bergström S: Isolation structure and action of the prostaglandins. In Nobel Symposium 2, Prostaglandins. S, Sammuelson B (eds): Bergström 1967, p. 21 Stockholm.
Bergström S, Carlson LA, Ekelund L, et al: Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Acta Physiol Scand 64:332, 1965
Bergström S, Duner H, von Euler US, et al: Observations on the effects of infusion of prostaglandin E1 in man. Acta Physiol Scand 45:145, 1959
Berman HJ, Tangen O, Ausprunk D: Prostaglandin E1 inhibition of aggregation of hamster platelets. 5th European Conference on Microcirculation. Bib Anat 10:507, 1969
Born GVR: Observations on the rapid morphological reaction of platelets to aggregating agents. Ser Haemetol 3(4): 114, 1970
Born GVR: Platelets in thrombogenesis. Mechanism and inhibition of platelet aggregation. Ann Coll Surg Engl 36:200, 1965
Boullin DJ, Green AR, Price KS: The mechanism of ADP-induced platelet aggregation binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E1. J Physiol 221:415, 1972
Bousser M: Effects of combined prostaglandin E1 and aspirin on experimental arterial thrombosis in rabbits. Biomedicine 19:90, 1973
Brodie GN, Baeuziger N, Chase L: The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets. Clin Invest 51:81, 1972
Butcher RW: Prostaglandins and cyclic-AMP. In Greengard P, Costa E (eds): Advances in Biochemical Psychopharmacology, Vol. 3. 1970, p. 173
Carlson LA, Ekelund L, Orö L: Clinical and metabolic effects of different doses of prostaglandin E1 in Man. Acta Med Scand 183:423, 1968
Carlson LA, Irion E, Orö L: Effect of infusion of prostaglandin E1 on the aggregation of blood platelets in man. Life Sci 7:85, 1968
Clausen J, Srivastava KC: The synthesis of prostaglandins in human platelets. Lipids 7(4):246, 1972
Droller MJ, Wolfe S: Thrombin-induced increase in intracellular cyclic 3’5’-adenosine monophosphate in human platelets. J Clin Invest 51:3094, 1972
Elkeles RS, Hampton JR, Harrison MJ: Prostaglandin E1 and human platelets. Lancet 2:111, 1969
Emmons PR, Hampton JR, Harrison MJ, et al: Effect of prostaglandin E1 on platelet behavior in vitro and in vivo. Br Med J 2:468, 1967
Evans G, Mustard J: Platelet-surface reaction and thrombosis. Surgery 64:273, 1968
Glenn E, Wilks J, Bowman B: Platelets, prostaglandins, red cells, sedimentation rates, serum and tissue proteins and non-steroidal anti-inflammatory drugs. Proc Soc Exp Biol Med 141:879, 1972
Grottenlos J, Hornstra G: The influence of prostaglandin E1 on experimental platelet aggregation in rats. In Jones JR (ed): Proceedings of the 2nd International Symposium on Atherosclerosis, Chicago, 1969. New York Heidelberg Berlin, Springer-Verlag, 1970
Hinman J: The prostaglandins. Bioscience 17:779, 1967
Hornstra G: Degree and duration of prostaglandin E1-induced inhibition of platelet aggregation in the rat. Eur Pharmacol 15:343, 1971
Horton EW: Hypothesis on physiological roles of prostaglandins. Physiol Rev 49:122, 1969
Horton EW: The prostaglandins. In Staey RS, Robson JM (eds): Recent Advances in Pharmacology, 4th ed. p.186
Irion E, Blomback M: Prostaglandins in platelet aggregation. Scand J Clin Lab Invest 24:141, 1969
Jorgensen H, Sondergaard J: Vascular responses to prostaglandin E1. Acta Derm Vener. (Stockh) 53:203, 1973
Kaegi H, Pineo G, Shimizu A, et al: Arterio-venous shunt thrombosis, prevention by sulfinpyrayone. N Engl J Med 290:304, 1974
Kaley G, Weiner R: Microcirculatory studies with prostaglandin E1. In Ramwell PW, Shaw JE (eds): Prostaglandin Symposium of the Worchester Foundation for Experimental Biology. New York, Wiley Inter-science, 1968
Karim SMM (ed): Prostaglandin, Progress in Research. New York, Wiley Inter-science, 1972, p 240
Ketchum LD, Wennen WW, Masters FW, and Robinson DW: Experimental use of pluronic F68 in microvascular surgery. Plast Re-const Surg 53:288, 1974
Kloeze J: Influence of prostaglandins on platelet adhesives and platelet aggregation. In Bergström S, Sammuelson B(eds): Nobel Symposium 2, Prostaglandins. Stockholm, 1967, p241
Kloeze J: Relationship between chemical structure and platelet aggregation activity of prostaglandins. Biochem Biophys Acta 187:285, 1969
Kloeze J: Influence of prostaglandins on ADP-induced platelet aggregation. Netherlands Society for Physiology and Pharmacology Meeting, April 6, 1967
Kloeze J: Influence of Prostaglandins E1 and E2 on coagulation of rat blood. Experientia 26:307, 1970
Kluge TH, et al: Thrombosis prophylaxis with dextran and warfarin in vascular operations. Surg Gynecol Obstet 135:941, 1972
Lee J, et al: Prostaglandins as therapeutic agents. Arch Intern Med 131:294, 1973
Marquis N, Becker J, Vigdahl R: Platelet aggregation and epinepherine-induced decrease in cyclic-AMP synthesis. Biochem and Biophys Res Commun 39:783, 1970
Marquis N, Vigdahl R, Tavorina P: Biochemical role of prostaglandin E1 in the inhibition of platelet aggregation. Second International Symposium on Atherosclerosis, Chicago, 1969
Marquis N, Vigdahl R, Tavorina P: Platelet aggregation regulation by cyclic-AMP and prostaglandin E1. Biochem Biophys Res Commun 36:965, 1969
Mattila S, Fogarty T: Heterologous vascular grafts as small vessel substitutes. Annales, Chir Gynaecol Fenn 62:234, 1973
Mayer J, Hammond G: Dipyridamole and aspirin tested against an experimental model of thrombosis. Ann Surg 178:108, 1973
Mills D, Smith J: The control of platelet responsiveness by agents that influence cyclic-AMP metabolism. Ann NY Acad Sci 201:391, 1972
Mills D, Smith J: The influence of platelet aggregation of drugs that affect the accumulation of adenosine 3′,5′ cyclic monophosphate in platelets. Biochem J 121:185, 1971
Mustard J: Platelets, drugs, and Thrombosis. CMAJ 108:443, 1973
Mustard J, Packham M: Thromboembolism. A manifestation of the response of blood injury. Circulation 42:1, 1970
Mustard JF, Rowsell HC, Smythe HA: The effect of sulfinpyrazone on platelet economy and thrombosis formation in rabbits. Blood 29:859, 1967
Nakano T: Effects of prostaglandins E1, A1, F2 on the coronary and peripheral circulation. Proc Soc Exp Biol Med 127:1160, 1968
Nomoto H, Buncke HJ, Chater NL: Improved patency rates in microvascular surgery when using magnesium sulfate and a silicone rubber vascular cuff. Plast Reconstr Surg 54:157, 1974
O’Brien J, Henderson P, Bennett RC, Crock GW: Microvascular surgical techniques. Med J Aust 1:722, 1970
O’Brien J, Tulevski V, Etherington M, Madgwick T: Platelet function studies before and after operation and the effect of post-operative thrombosis. J Lab Clin Med 83:342 1974
Pelofsky S, Jacobson E, Fisher R: Effects of prostaglandin E1 on experimental cerebral vasospasm. J Neurosurg 36:634, 1972
Pickles V: Prostaglandins. Nature 224:221, 1969
Salzman E: Cyclic AMP and platelet function. N Engl J Med 286:358, 1972
Salzman E, Levine L: Cyclic 3’,5’-adenosine monophosphate in human blood platelets. J Clin Invest 50:131, 1971
Silver MF, et al: Human blood prostaglandins. Formation during clotting. Prostaglandins 1:429, 1972
Smith E, McMorrow J, Covino B, et al: Studies on the vasodilator action of prostaglandin E1. In Ramwell PW, Shaw JE (eds): Prostaglandin Symposium of the Worchester Foundation for Experimental Biology. New York, Wiley Interscience 1968, p 259
Smith J, Ingerman C, Kocsis JJ, Silver MJ: Formation of prostaglandins during the aggregation of human blood platelets. J Clin Invest 52:965, 1973
Smythe H, Ogryzlo MA, Murphy EA, et al: The effect of sulfinpyrazone on platelet economy and blood coagulation in man. Can Med Assoc J 92:818, 1965
Sondergaard J, Helin P, Jorgensen H: Human cutaneous inflammation induced by prostaglandin E1. J Pathol 109:239, 1973
Steiner L, Forster D, Bergvall U, et al: Effect of prostaglandin E1 on cerebral circulatory disturbances following subarachnoid haemorrhage in man. Neuroradiology 4:409, 1972
Tuttle R, Skelly M: Interactions of prostaglandin E1 and ouabain on Contractility of isolated rabbit atria and intracellular cation concentration. In Ramwell S, Shaw JE (eds): Prostaglandin Symposium of the Worchester Foundation for Experimental Biology. New York, Wiley Inter-science 1968, p 309
Van Crevald S, Pascha CN: Influence of the prostaglandins E1 and E2 on aggregation of blood platelets. Nature 218:316, 1968
Van Crevald S, Pascha CN: Abnormality in the aggregation of blood platelets in various morbid conditions and the influence of prostaglandins upon this abnormality. Thromb Diath Haemorrh 20:180, 1968
Vigdahl R, Marquis N, Tavormina P: Platelet aggregation, Adenyl Cyclase, Prostaglandin E1 and Calcium. Biochem Biophys Res Commun 37:409, 1969
Viguera M, Sunahara F: Microcirculatory effects of prostaglandins. Can J Physiol Pharmacol 47:627, 1969
Weeks J, Sekhar N, Ducharme D: Relative activity of prostaglandins E1, A1, E2, and A2 on lipolysis, platelet aggregation, smooth muscle and the cardiovascular system. J Pharm Pharmacol 21:103, 1969
Wolfe S, Shulman N: Adenyl cyclase activity in human platelets. Biochem Biophys Res Commun 35:266, 1969
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Lamond, R.G., Chater, N.L. (1978). The experimental effects of prostaglandin E1 on small vessel patency. In: Fein, J.M., Reichman, O.H. (eds) Microvascular Anastomoses for Cerebral Ischemia. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-9911-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4612-9911-0_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-9913-4
Online ISBN: 978-1-4612-9911-0
eBook Packages: Springer Book Archive